What is recommended for mild AMD management?

What is recommended for mild AMD management?

• A. UV protection, smoking cessation, daily antioxidant-containing multivitamin
• B. AREDS II only
• C. Laser therapy
• D. Immediate anti-VEGF

Answer: (A)

In mild AMD, the emphasis is on slowing progression through risk-factor modification and nutritional support rather than invasive therapy. Protecting the eyes from oxidative stress and reducing modifiable risks can help preserve vision longer. UV protection helps minimize light-induced oxidative damage to the retina. Smoking cessation is important because smoking increases oxidative stress and inflammation, accelerating AMD progression. A daily antioxidant-containing multivitamin—such as the AREDS-type formulation used in AMD research—provides vitamins and minerals with evidence suggesting a reduction in the risk of progression to more advanced stages, especially when tailored (for example, lutein and zeaxanthin can be used instead of beta-carotene in smokers). Laser therapy and anti-VEGF injections are therapies aimed at neovascular (wet) AMD or other advanced conditions and are not indicated for mild dry AMD. If structural changes worsen and AMD becomes intermediate or neovascular, treatment approaches may change, but for mild AMD the combination of protective measures and appropriate supplementation is the recommended approach.

In mild AMD, the emphasis is on slowing progression through risk-factor modification and nutritional support rather than invasive therapy. Protecting the eyes from oxidative stress and reducing modifiable risks can help preserve vision longer.

UV protection helps minimize light-induced oxidative damage to the retina. Smoking cessation is important because smoking increases oxidative stress and inflammation, accelerating AMD progression. A daily antioxidant-containing multivitamin—such as the AREDS-type formulation used in AMD research—provides vitamins and minerals with evidence suggesting a reduction in the risk of progression to more advanced stages, especially when tailored (for example, lutein and zeaxanthin can be used instead of beta-carotene in smokers).

Laser therapy and anti-VEGF injections are therapies aimed at neovascular (wet) AMD or other advanced conditions and are not indicated for mild dry AMD. If structural changes worsen and AMD becomes intermediate or neovascular, treatment approaches may change, but for mild AMD the combination of protective measures and appropriate supplementation is the recommended approach.